These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33616771)

  • 21. Radicalizing moral conservatism in herd immunity during COVID-19.
    Kahambing JG
    J Public Health (Oxf); 2022 Dec; 44(4):e606-e607. PubMed ID: 34297131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What to Do in the Next Pandemic Outbreak: Natural Herd Immunity Versus Lockdown (Lessons Learned from COVID-19).
    Raposo VL
    J Law Med; 2022 Mar; 29(1):260-269. PubMed ID: 35362294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficiency in the governance of the Covid-19 pandemic: political and territorial factors.
    Martínez-Córdoba PJ; Benito B; García-Sánchez IM
    Global Health; 2021 Sep; 17(1):113. PubMed ID: 34548073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL
    Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Political discourse, denialism and leadership failure in Brazil's response to COVID-19.
    Fonseca EMD; Nattrass N; Lazaro LLB; Bastos FI
    Glob Public Health; 2021; 16(8-9):1251-1266. PubMed ID: 34161187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transparent scientific reporting is imperative during the pandemic.
    Agoramoorthy G; Hsu MJ; Shieh P
    Pathog Glob Health; 2021 May; 115(3):135-136. PubMed ID: 33475047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herd Immunity Against Coronavirus: A Review.
    Datta S; Roy A
    Recent Pat Biotechnol; 2022 Aug; 16(3):256-265. PubMed ID: 35400332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Democracy, Capacity, and Coercion in Pandemic Response: COVID-19 in Comparative Political Perspective.
    Kavanagh MM; Singh R
    J Health Polit Policy Law; 2020 Dec; 45(6):997-1012. PubMed ID: 32464665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herd Immunity: Understanding COVID-19.
    Randolph HE; Barreiro LB
    Immunity; 2020 May; 52(5):737-741. PubMed ID: 32433946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fighting against COVID-19: With or without politics?
    Kovanic M; Steuer M
    Soc Sci Med; 2023 Nov; 337():116297. PubMed ID: 37832315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Appointment in Samarra: A New Use for Some Old Jokes.
    Žižek S
    J Bioeth Inq; 2020 Dec; 17(4):473-478. PubMed ID: 32840846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Solidarity, covid-19 and a lever without fulcrum.].
    Saracci R
    Recenti Prog Med; 2022 Jan; 113(1):24-29. PubMed ID: 35044372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid evolution of the COVID-19 pandemic calls for a unified public health response.
    He N
    Biosci Trends; 2021 Sep; 15(4):196-200. PubMed ID: 34193749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Vaccine-Related Discussion on Twitter: Topic Modeling and Sentiment Analysis.
    Lyu JC; Han EL; Luli GK
    J Med Internet Res; 2021 Jun; 23(6):e24435. PubMed ID: 34115608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bio-Politics and Calculative Technologies in COVID-19 Governance: Reflections From England.
    Jayasinghe K; Jayasinghe T; Wijethilake C; Adhikari P
    Int J Health Policy Manag; 2022 Oct; 11(10):2189-2197. PubMed ID: 34814665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How have researchers defined institutions, politics, organizations and governance in research related to epidemic and pandemic response? A scoping review to map current concepts.
    Wu A; Khanna S; Keidar S; Berman P; Brubacher LJ
    Health Policy Plan; 2023 Mar; 38(3):377-393. PubMed ID: 36308404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
    Kouamou V; Matarise R; Santos ED; Elose N; Manasa J
    Pan Afr Med J; 2021; 39():255. PubMed ID: 34707756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
    Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
    Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of immunology in news and YouTube videos in the context of COVID-19: politicisation and information bubbles.
    George RS; Goodey H; Russo MA; Tula R; Ghezzi P
    Front Public Health; 2024; 12():1327704. PubMed ID: 38435297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.